Laura Fouassier
Paris, 75006, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Correction: Gonzalez-Sanchez et al. Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential. Int. J. Mol. Sci. 2025, 26, 11135.
Journal: International journal of molecular sciences
Published: June 22, 2026
Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 17, 2025
Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential.
Journal: International journal of molecular sciences
Published: September 15, 2025
A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reaction.
Journal: JHEP reports : innovation in hepatology
Published: May 03, 2025
Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 blockade and T cell response in cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: January 30, 2025
Loss of Aquaporin-1 in Tumor Cells Fosters Intrahepatic Cholangiocarcinoma Progression.
Journal: The American journal of pathology
Published: January 18, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.
Journal: Signal transduction and targeted therapy
Published: September 02, 2024
Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2024
Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 30, 2023
Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment.
Journal: Current oncology (Toronto, Ont.)
Published: February 03, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.
Journal: Nature reviews. Gastroenterology & hepatology
Published: December 20, 2022
Last Updated: 09/26/2026